KURA ONCOLOGY, INC. Shares Outstanding (Cover Page)
KURA ONCOLOGY, INC. (KURA) had Shares Outstanding (Cover Page) of 88.96 million shares as of 2026-08-07, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-07: Entity Common Stock, Shares Outstanding 88.96M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 88.77M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 88.33M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 87.02M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 88.96M shares 10-Q · filed 2026-08-12 |
| 2026-05-08 | 88.77M shares 10-Q · filed 2026-05-12 |
| 2026-02-27 | 88.33M shares 10-K · filed 2026-03-05 |
| 2025-10-31 | 87.02M shares 10-Q · filed 2025-11-04 |
| 2025-08-01 | 86.80M shares 10-Q · filed 2025-08-07 |
| 2025-04-28 | 86.57M shares 10-Q · filed 2025-05-01 |
| 2025-02-20 | 80.75M shares 10-K · filed 2025-02-28 |
| 2024-11-04 | 77.76M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 76.63M shares 10-Q · filed 2024-08-08 |
| 2024-04-26 | 76.18M shares 10-Q · filed 2024-05-02 |
| 2024-02-20 | 76.14M shares 10-K · filed 2024-02-27 |
| 2023-10-26 | 74.27M shares 10-Q · filed 2023-11-02 |
| 2023-08-03 | 74.24M shares 10-Q · filed 2023-08-09 |
| 2023-05-04 | 68.44M shares 10-Q · filed 2023-05-10 |
| 2023-02-17 | 68.44M shares 10-K · filed 2023-02-23 |
| 2022-10-27 | 66.90M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 66.89M shares 10-Q · filed 2022-08-03 |
| 2022-04-29 | 66.64M shares 10-Q · filed 2022-05-04 |
| 2022-02-18 | 66.61M shares 10-K · filed 2022-02-24 |
| 2021-11-01 | 66.56M shares 10-Q · filed 2021-11-04 |
| 2021-08-02 | 66.30M shares 10-Q · filed 2021-08-05 |
| 2021-05-03 | 66.27M shares 10-Q · filed 2021-05-06 |
| 2021-02-19 | 66.21M shares 10-K · filed 2021-02-24 |
| 2020-11-02 | 56.71M shares 10-Q · filed 2020-11-05 |
| 2020-08-03 | 56.28M shares 10-Q · filed 2020-08-06 |
| 2020-04-30 | 45.44M shares 10-Q · filed 2020-05-04 |
| 2020-02-20 | 45.43M shares 10-K · filed 2020-02-25 |
| 2019-11-01 | 45.31M shares 10-Q · filed 2019-11-05 |
| 2019-07-30 | 45.21M shares 10-Q · filed 2019-08-01 |
| 2019-05-03 | 38.18M shares 10-Q · filed 2019-05-07 |
| 2019-03-01 | 38.17M shares 10-K · filed 2019-03-05 |
| 2018-10-31 | 38.04M shares 10-Q · filed 2018-11-05 |
| 2018-08-03 | 37.98M shares 10-Q · filed 2018-08-06 |
| 2018-05-04 | 33.35M shares 10-Q · filed 2018-05-08 |
| 2018-03-09 | 33.35M shares 10-K · filed 2018-03-12 |
| 2017-11-03 | 30.22M shares 10-Q · filed 2017-11-07 |
| 2017-08-02 | 21.37M shares 10-Q · filed 2017-08-07 |
| 2017-05-12 | 21.41M shares 10-Q · filed 2017-05-15 |
| 2017-03-10 | 21.38M shares 10-K · filed 2017-03-14 |
| 2016-11-02 | 21.37M shares 10-Q · filed 2016-11-07 |
| 2016-08-04 | 21.37M shares 10-Q · filed 2016-08-10 |
| 2016-05-06 | 21.37M shares 10-Q · filed 2016-05-11 |
| 2016-03-11 | 21.37M shares 10-K · filed 2016-03-17 |
| 2015-11-13 | 21.37M shares 10-Q · filed 2015-11-13 |
| 2015-08-12 | 14.51M shares 10-Q · filed 2015-08-14 |
| 2015-05-11 | 14.51M shares 10-Q · filed 2015-05-13 |
| 2015-02-27 | 5.00M shares 10-K · filed 2015-02-27 |
| 2014-11-14 | 5.00M shares 10-Q · filed 2014-11-14 |
| 2014-08-14 | 5.00M shares 10-Q · filed 2014-08-14 |
| 2014-05-15 | 5.00M shares 10-Q · filed 2014-05-15 |
| 2014-03-31 | 5.00M shares 10-K · filed 2014-03-31 |
| 2013-11-14 | 5.00M shares 10-Q · filed 2013-11-14 |
| 2013-08-14 | 5.00M shares 10-Q · filed 2013-08-14 |
| 2013-05-15 | 5.00M shares 10-Q · filed 2013-05-15 |
| 2013-03-28 | 5.00M shares 10-K · filed 2013-03-28 |
| 2012-11-14 | 5.00M shares 10-Q · filed 2012-11-14 |
| 2012-08-14 | 5.00M shares 10-Q · filed 2012-08-14 |
| 2012-05-15 | 5.00M shares 10-Q · filed 2012-05-15 |
| 2011-12-31 | 0.00 shares 10-K · filed 2012-03-30 |
| 2011-11-14 | 5.00M shares 10-Q · filed 2011-11-14 |
| 2011-08-09 | 5.00M shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |